TransEnterix's robot-assisted surgery device, Senhance Surgical System, has been cleared by Japanese regulators.
Three things to know:
1. The robot has been approved for laparoscopy for general surgery, gynecology, urology and specific thoracic procedures.
2. Senhance's goal is to improve the precision, senses and control of surgeons in minimally invasive laparoscopic procedures.
3. "Japan is second only to the U.S. as the world's largest surgical robotics market" and "creates a considerable market opportunity for Senhance," said Todd M. Pope, president and CEO of TransEnterix.